ClinicalTrials.Veeva

Menu

Finding the Invasive Haemodynamic Threshold for Symptom Relief in Stable Angina (ORBITA-FIRE)

Imperial College London logo

Imperial College London

Status

Enrolling

Conditions

Stable Angina

Treatments

Diagnostic Test: Rest-angina physiological assessment
Diagnostic Test: Exercise-angina physiological assessment

Study type

Observational

Funder types

Other

Identifiers

NCT05459051
22HH7546 (Other Identifier)
P91528

Details and patient eligibility

About

ORBITA-FIRE is a randomised, double-blinded, placebo controlled experimental study that will identify the fractional flow reserve (FFR) and non-hyperemic pressure ratio (NHPR) thresholds that correlate with symptoms of angina for 58 patients measured invasively under experimental conditions.

Enrollment

58 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Eligibility for percutaneous coronary intervention (PCI) due to angina or angina-equivalent symptoms on exertion

  • Anatomical evidence of significant single-vessel coronary stenosis defined by either:

    • ≥70% stenosis on invasive coronary angiography (ICA)
    • Severe stenosis on CT coronary angiography (CTCA)
  • Physiological evidence of ischaemia with a positive test on at least one of the following:

    • Stress echocardiography
    • Cardiac magnetic resonance perfusion
    • Myocardial perfusion scintigraphy
    • Invasive metrics of coronary physiology

Exclusion criteria

  • Age <18 years
  • Recent acute coronary syndrome
  • Previous coronary artery by-pass graft
  • Significant left main stem disease
  • Multivessel disease (defined as >50% angiographic stenosis in other vessels)
  • Chronic total occlusion in the target artery
  • Moderate to severe valvular disease
  • Moderate to severe left ventricular impairment
  • Chronotropic incompetence with a pacemaker
  • Contraindication to PCI or a drug-eluting stents
  • Contraindication to antiplatelet therapy
  • Contraindication to adenosine
  • Moderate to severe respiratory disease
  • Physical inability to exercise
  • Pregnant
  • Inability to consent

Trial design

58 participants in 1 patient group

Patients with stable angina
Description:
* Symptomatic * Anatomically severe single-vessel coronary artery disease * Physiological evidence of myocardial ischaemia
Treatment:
Diagnostic Test: Exercise-angina physiological assessment
Diagnostic Test: Rest-angina physiological assessment

Trial contacts and locations

6

Loading...

Central trial contact

Fiyyaz Ahmed-Jushuf, MBBS MRCP; Rasha Al-Lamee, PhD MRCP

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems